Phytomedicine,
Journal Year:
2021,
Volume and Issue:
96, P. 153905 - 153905
Published: Dec. 25, 2021
Chronic
migraine
(CM)
is
a
highly
disabling
and
burdensome
disease.
Wuzhuyu
decoction
(WZYD),
clinical
used
formula
to
treat
prevent
episodic
CM,
has
been
reported
relieve
the
hyperalgesia
of
CM
increase
brainstem
blood
serotonin
(5-hydroxytryptamine,
5-HT)
in
model
rats
previous
studies;
yet
mechanism
unclear.This
study
aimed
observe
relief
effect
WZYD
investigate
mechanistic
association
with
regulation
on
central
peripheral
5-HT.WZYD
different
doses
(3.372,
1.686
0.843
g/kg∙d)
positive
drug
-
sumatriptan
(5.83
mg/kg∙3
d)
were
intragastrically
administered
inflammatory
soup
(IS)-induced
rats,
respectively.
Hyperalgesia
was
assessed
by
facial
mechanical
withdrawal
threshold
tail-flick
latency.
5-HT
determined
ELISA.
Western
blot
analysis,
immunohistochemistry
immunofluorescence
determination,
16S
rRNA
gene
sequencing
performed.WZYD
significantly
relieved
elevating
In
groups,
increased
decreased
calcitonin
gene-related
peptide
both
plasma,
downregulated
TNF-α,
IL-1β,
c-fos
expression
observed
dose-dependent
manner.
Interestingly,
colon
tissues
also
observed,
which
associated
upregulating
tryptophan
hydroxylase,
transporter
Piezo1
increasing
chromogranin
A
enterochromaffin
cells.
Disorder
microbiota,
function
metabolism
correlated
synthesis.
could
regulate
abundance
Anaerostipes
Acidifaciens.WZYD
pharmacological
relieving
possibly
affecting
5-HT.
Physiological Reviews,
Journal Year:
2022,
Volume and Issue:
103(2), P. 1487 - 1564
Published: Dec. 15, 2022
Of
all
the
organ
systems
in
body,
gastrointestinal
tract
is
most
complicated
terms
of
numbers
structures
involved,
each
with
different
functions,
and
types
signaling
molecules
utilized.
The
digestion
food
absorption
nutrients,
electrolytes,
water
occurs
a
hostile
luminal
environment
that
contains
large
diverse
microbiota.
At
core
regulatory
control
digestive
defensive
functions
enteric
nervous
system
(ENS),
complex
neurons
glia
gut
wall.
In
this
review,
we
discuss
1)
intrinsic
neural
involved
2)
how
ENS
interacts
immune
system,
microbiota,
epithelium
to
maintain
mucosal
defense
barrier
function.
We
highlight
developments
have
revolutionized
our
understanding
physiology
pathophysiology
control.
These
include
new
molecular
architecture
ENS,
organization
function
motor
circuits,
roles
glia.
explore
transduction
stimuli
by
enteroendocrine
cells,
regulation
intestinal
glia,
local
role
microbiota
regulating
structure
ENS.
Multifunctional
work
together
glial
macrophages,
interstitial
cells
integrating
an
array
signals
initiate
outputs
are
precisely
regulated
space
time
homeostasis.
Nature Neuroscience,
Journal Year:
2022,
Volume and Issue:
25(2), P. 191 - 200
Published: Jan. 13, 2022
Guided
by
gut
sensory
cues,
humans
and
animals
prefer
nutritive
sugars
over
non-caloric
sweeteners,
but
how
the
steers
such
preferences
remains
unknown.
In
intestine,
neuropod
cells
synapse
with
vagal
neurons
to
convey
sugar
stimuli
brain
within
seconds.
Here,
we
found
that
cholecystokinin
(CCK)-labeled
duodenal
differentiate
transduce
luminal
from
sweeteners
vagus
nerve
using
sweet
taste
receptors
sodium
glucose
transporters.
The
two
stimulus
types
elicited
distinct
neural
pathways:
while
sweetener
stimulated
purinergic
neurotransmission,
glutamatergic
neurotransmission.
To
probe
contribution
of
these
behavior,
developed
optogenetics
for
lumen
engineering
a
flexible
fiberoptic.
We
showed
preference
in
mice
depends
on
cell
signaling.
By
swiftly
discerning
precise
identity
nutrient
stimuli,
serve
as
entry
point
guide
choices.
JGH Open,
Journal Year:
2021,
Volume and Issue:
5(9), P. 976 - 987
Published: March 23, 2021
Functional
gastrointestinal
disorders
(FGIDs),
currently
known
as
of
gut-brain
interaction,
are
emerging
microbiota-gut-brain
abnormalities
that
prevalent
worldwide.
The
pathogenesis
FGIDs
is
heterogeneous
and
intertwined
with
gut
microbiota
its
derived
molecule-modulated
mechanisms,
including
dysmotility,
visceral
hypersensitivity,
immune
abnormalities,
abnormal
secretion,
impaired
barrier
function.
There
has
been
phenomenal
progress
in
understanding
the
role
by
underpinning
species
alternations
between
healthy
pathological
conditions
such
FGIDs.
However,
precise
microbiota-directed
cellular
molecular
pathogeneses
yet
enigmatic.
Determining
mechanistic
link
(GI)
diseases
difficult
due
to
(i)
lack
robust
animal
models
imitating
various
aspects
human
FGID
pathophysiology;
(ii)
absence
longitudinal
and/or
studies
unveil
interaction
FGID-relevant
pathogenesis;
(iii)
uncertainty
about
connections
studies;
(iv)
insufficient
data
supporting
a
holistic
view
disease-specific
pathophysiological
changes
patients.
These
unidentified
gaps
open
possibilities
explore
mechanisms
directed
through
dysbiosis
current
treatment
options
for
dysbiotic
limited;
dietary
interventions,
antibiotics,
probiotics,
fecal
transplantation
front-line
clinical
options.
Here,
we
review
contribution
molecules
homeostasis
possible
involved
leading
potential
therapeutics
Frontiers in Pharmacology,
Journal Year:
2022,
Volume and Issue:
13
Published: Jan. 25, 2022
Functional
gastrointestinal
disorders
(FGIDs)
have
been
re-named
as
of
gut-brain
interactions.
These
conditions
are
not
only
common
in
clinical
practice,
but
also
the
community.
In
reference
to
Rome
IV
criteria,
most
FGIDs,
include
functional
dyspepsia
(FD)
and
irritable
bowel
syndrome
(IBS).
Additionally,
there
is
substantial
overlap
these
other
specific
motility
disorders,
such
gastroparesis.
heterogeneous
intertwined
with
several
proposed
pathophysiological
mechanisms,
altered
gut
motility,
intestinal
barrier
dysfunction,
immune
visceral
hypersensitivity,
GI
secretion,
presence
degree
bile
acid
malabsorption,
microbial
dysbiosis,
alterations
axis.
The
treatment
options
currently
available
lifestyle
modifications,
dietary
microbiota
manipulation
interventions
including
fecal
transplantation,
prokinetics,
antispasmodics,
laxatives,
centrally
peripherally
acting
neuromodulators.
However,
that
targets
mechanisms
underlying
symptoms
scanty.
Pharmacological
agents
developed
based
on
cellular
molecular
pathologies
might
provide
best
avenue
for
future
pharmaceutical
development.
therapies
lack
long-term
effectiveness
safety
their
use
treat
FGIDs.
Furthermore,
fundamental
challenges
treating
should
be
defined;
instance,
1.
Cause
effect
cannot
disentangled
between
due
current
entail
off-label
medications
symptoms.
2.
Despite
knowledge
our
plays
an
essential
part
maintaining
health,
exact
functions
homeostasis
still
unclear.
What
constitutes
a
healthy
microbiome
further,
precise
definition
dysbiosis
lacking.
More
comprehensive,
large-scale,
longitudinal
studies
utilizing
multi-omics
data
needed
dissect
contribution
disease
pathogenesis.
Accordingly,
we
review
options,
insight
pathophysiology,
therapeutic
modalities,
challenges,
clues
care
management
dyspepsia,
gastroparesis,
syndrome,
constipation,
diarrhea.
Pharmaceuticals,
Journal Year:
2024,
Volume and Issue:
17(2), P. 153 - 153
Published: Jan. 24, 2024
Xiao
Cheng
Qi
(XCQ)
decoction,
an
ancient
Chinese
herbal
mixture,
has
been
used
in
treating
slow-transit
constipation
(STC)
for
years.
The
underlying
action
mechanism
relieving
the
clinical
symptoms
is
unclear.
Several
lines
of
evidence
point
to
a
strong
link
between
and
gut
microbiota.
Short-chain
fatty
acids
(SCFAs)
microbial
metabolites
have
shown
affect
5-HT
synthesis
by
activating
GPR43
receptor
localized
on
intestinal
enterochromaffin
cells,
since
receptors
are
known
influence
colonic
peristalsis.
objective
this
study
was
evaluate
efficacy
XCQ
alleviating
mouse
model
STC
induced
loperamide.
application
loperamide
leads
decrease
transport
fecal
water,
which
establish
animal
STC.
In
addition,
relationship
microbiota
determined.
materials,
composed
Rhei
Radix
et
Rhizoma
(Rhizomes
Rheum
palmatum
L.,
Polygonaceae)
55.2
g,
Magnoliae
Officinalis
Cortex
(Barks
Magnolia
officinalis
Rehd.
Wils,
Magnoliaceae)
27.6
Aurantii
Fructus
Immaturus
(Fruitlet
Citrus
aurantium
Rutaceae)
36.0
were
extracted
with
water
prepare
decoction.
constipated
mice
(10
mg/kg/day),
then
treated
oral
dose
extract
(2.0,
4.0,
8.0
g/kg/day)
two
times
day.
Mosapride
administered
as
positive
drug.
loperamide-induced
mice,
therapeutic
parameters
XCQ-treated
determined,
i.e.,
(i)
constipation,
composition
microbiota,
amount
short-chain
feces;
(ii)
plasma
level
5-HT;
(iii)
expressions
5-HT4
colon.
ameliorated
mice.
treatment
increased
relative
abundances
Lactobacillus,
Prevotellaceae_UCG_001,
Prevotellaceae_NK3B31_group,
Muribaculaceae,
Roseburia
feces
decreased
Desulfovibrio,
Tuzzerella,
Lachnospiraceae_
NK4A136_group.
levels
SCFAs
stools
from
group
significantly
lower
than
those
control
group,
greatly
elevated
via
XCQ.
Compared
receptor,
significantly.
anti-constipation
could
be
related
modulation
increase
SCFAs,
5-HT,
receptor.
Our
results
indicate
that
potent
natural
product
strategy
constipation.
AJP Gastrointestinal and Liver Physiology,
Journal Year:
2022,
Volume and Issue:
322(5), P. G523 - G533
Published: March 16, 2022
Cross
talk
between
the
gastrointestinal
tract
and
brain
is
of
significant
relevance
for
human
health
disease.
However,
our
understanding
how
gut
communicate
has
been
limited
by
a
lack
techniques
to
identify
precise
spatial
relationship
extrinsic
nerve
endings
their
proximity
specific
cell
types
that
line
inner
surface
tract.
We
used
an
in
vivo
anterograde
tracing
technique,
previously
developed
laboratory,
selectively
label
single
spinal
afferent
axons
mouse
colonic
mucosa.
The
closest
three-dimensional
distances
axonal
varicosities
enterochromaffin
(EC)
cells,
which
contain
serotonin
(5-hydroxytryptamine;
5-HT),
were
then
measured.
mean
(±
standard
deviation)
any
varicosity
along
axon
or
its
ending,
nearest
EC
cell,
5.7
±
6.0
μm
(median:
3.6
μm)
26.9
18.6
24.1
μm),
respectively.
Randomization
location
cells
revealed
similar
results
this
actual
data.
These
are
∼200-1,000
times
greater
than
those
pre-
postsynaptic
membranes
(15-25
nm)
underlie
synaptic
transmission
vertebrate
nervous
system.
Our
findings
suggest
5-HT-containing
release
substances
activate
centrally
projecting
nerves
likely
via
diffusion,
as
such
signaling
unlikely
occur
with
fidelity
synapse.NEW
&
NOTEWORTHY
show
absence
close
physical
contact
Similar
relative
observed
randomized
afferents
compared
This
suggests
released
from
act
neighboring
relay
sensory
information
lumen
brain.
ACS Nano,
Journal Year:
2023,
Volume and Issue:
17(7), P. 6410 - 6422
Published: March 29, 2023
Micro-/nanorobots
have
attracted
great
interest
in
the
field
of
drug
delivery
and
treatment,
while
preparations
for
biocompatible
robots
are
extremely
challenging.
Here,
a
self-driving
yeast
micro-/nanorobot
(Cur@CaY-robot)
is
designed
via
dual
biomineralization
acid
catalysis
calcium
carbonate
(CaCO3).
Inner
nano-CaCO3
inside
cells
(CaY)
biomineralized
through
cell
respiration
provides
nanoscaffolds
highly
encapsulating
curcumin
(Cur).
Meanwhile,
CaCO3
crystals
outside
(outer-CaCO3)
uniaxial
growth
offer
an
asymmetric
power
source
self-propelled
motility.
The
Cur@CaY-robot
displays
efficient
motion
gastric
acid,
with
potential
deep
penetration
to
thick
mucus,
which
significantly
improves
accumulation
agents
stomach
wall
tissue
robust
gastritis
therapy.
More
importantly,
Ca2+
cations
released
from
also
synergistically
repair
motility
mice.
Such
micro-/nanorobots
exhibit
desirable
biocompatibility
biodegradability
good
loading
capacity
drugs.
This
work
idea
design
environmentally
friendly
biosynthesis
strategy
active
precise
Cell and Tissue Research,
Journal Year:
2024,
Volume and Issue:
396(3), P. 313 - 327
Published: Feb. 22, 2024
Abstract
Understanding
how
the
gut
communicates
with
brain,
via
sensory
nerves,
is
of
significant
interest
to
medical
science.
Enteroendocrine
cells
(EEC)
that
line
mucosa
gastrointestinal
tract
release
neurochemicals,
including
largest
quantity
5-hydroxytryptamine
(5-HT).
How
substances,
like
5-HT,
from
enterochromaffin
(EC)
activates
vagal
afferent
nerve
endings
unresolved.
We
performed
anterograde
labelling
nodose
ganglia
in
vivo
and
identified
axons
whole-mount
full-length
preparations
mouse
colon.
then
determined
spatial
relationship
between
mucosal-projecting
EC
situ
using
3D
imaging.
The
mean
distances
mucosa,
or
nearest
varicosities
along
axon
branches,
cell
were
29.6
±
19.2
μm
(
n
=
107,
N
6)
25.7
15.2
119,
6),
respectively.
No
made
close
contacts
cells.
are
many
hundreds
times
greater
than
known
pre-
post-synaptic
membranes
(typically
10–20
nm)
underlie
synaptic
transmission
vertebrates.
absence
any
physical
5-HT-containing
leads
inescapable
conclusion
mechanism
by
which
5-HT
ECs
colonic
occurs
a
paracrine
fashion,
activate
afferents.